Meta-analysis finds only small role for endogenous opioids in acute pain
A systematic review and meta-analysis of 67 double-blind, placebo-controlled studies (N=2706) examined whether blocking mu-opioid receptors with antagonists increased pain sensitivity in healthy volunteers during peripheral pain testing. The analysis found that opioid blockade was associated with only a slight increase in pain compared with placebo, equivalent to about 2.8 points on a 0-100 pain intensity scale, with evidence suggesting this effect may be somewhat overestimated due to reporting bias. The authors state that this small effect indicates endogenous opioids play a minor role in human acute pain regulation, with the most credible evidence for such regulation found specifically in placebo hypoalgesia studies.
Most relevant for: Researchers and clinicians studying pain physiology and the rationale for opioid-based analgesia, including those investigating placebo analgesia mechanisms.
Read the original at PainSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More pain management updates
- Network meta-analysis ranks opioid options for breakthrough cancer painOct 13, 2026
- PEG scale cut-off of 6 identifies high-impact pain in adolescentsOct 1, 2026
- Perspective proposes random-point acupuncture as improved sham controlOct 1, 2026
- Exercise reduces pain and improves function in pregnancy-related pelvic girdle painOct 1, 2026
- Triple-agonist retatrutide cuts weight, knee pain, sleep apnea eventsSep 29, 2026